Khoso Baluch has bought CRMD on 3 days since May 2017

Khoso Baluch is a global biopharmaceutical executive and corporate insider best known for serving as President & Chief Executive Officer of CorMedix Inc. (CRMD), where he led the company from October 2016 through October 2021.( During his tenure at CorMedix, he oversaw commercialization strategy and development activities for therapeutic products aimed at preventing and treating infectious and inflammatory diseases, and signed SEC filings as CEO of the company.( As an insider, he has reported ownership and trading in CorMedix shares under U.S. SEC Form 4 filings.(

Before joining CorMedix, Baluch spent approximately 24 years at Eli Lilly & Co., holding international leadership roles across Europe, the Middle East, and the United States in general management, business development, market access, and product leadership, where he helped launch major brands including Cialis, Byetta, Cimzia, Vimpat, and Neupro.( He has subsequently held board and advisory positions in multiple biotech firms, including serving as a director of Longeveron Inc. and other life sciences companies.( Baluch holds an MBA from Cranfield School of Management and a BSc in Aeronautical Engineering from City, University of London / St George’s.(

Written by Perplexity from public sources.